$ETRA
Electra Therapeutics, Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$7.20
▼-9.66%-$0.770Market open
Electra Therapeutics, Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ETRA down today? It is at $7.20 (-9.66%), and our scanner flagged it 77 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ETRA spikes, and full due diligence on ETRA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ETRA 77 times in the last 30 days. Create a free account to track $ETRA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ETRA from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystOther Material Event · Charter / Bylaw Change, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedOct 29, 2026 · 6 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Priced at $15/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Dong Quehuong (Kathy) Officer | Acquired (grant/award) | +455K 0.7% of company | n/a | 455K | n/a | Sep 21, 26 |
Parry Graham Officer | Acquired (grant/award) | +86K 0.1% of company | n/a | 86K | n/a | Sep 21, 26 |
Stagliano Nancy Director | Acquired (grant/award) | +256K 0.4% of company | n/a | 256K | n/a | Sep 21, 26 |
Koe Gary S. Officer | Acquired (grant/award) | +64K 0.1% of company | n/a | 64K | n/a | Sep 21, 26 |
Orbimed Advisors Llc Director | Acquired (grant/award) | +5.55M 9.1% of company | n/a | 4.79M | n/a | Sep 21, 26 |
Orbimed Advisors Llc Director | Bought (open market) | +1.33M 2.2% of company | added 24% | 6.89M | $20.0M at $15.00 | Sep 21, 26 |
Gordon Carl L Director | Acquired (grant/award) | +5.55M 9.1% of company | n/a | 4.79M | n/a | Sep 21, 26 |
Gordon Carl L Director | Bought (open market) | +1.33M 2.2% of company | added 24% | 6.89M | $20.0M at $15.00 | Sep 21, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on ETRA from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ETRA last traded at $7.20, down 9.66% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ETRA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ETRA 77 times in the last 30 days.
ETRA (Electra Therapeutics, Inc. Common stock) trades on XNAS, with a market cap of about $487M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ETRA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ETRA discussion
Sign in to ask a question or join the discussion.